Diabetic Medicine

Recommendations for designing tables that report randomized trials
pp. 1309-1312(4)
Authors: Johnson, E. S.; Stratton, I. M.

Stroke prediction and stroke prevention with atorvastatin in the Collaborative Atorvastatin Diabetes Study (CARDS)
pp. 1313-1321(9)
Authors: Hitman, G. A.; Colhoun, H.; Newman, C.; Szarek, M.; Betteridge, D. J.; Durrington, P. N.; Fuller, J.; Livingstone, S.; Neil, H. A. W.

Inverse correlation between activated protein C generation and carotid atherosclerosis in Type 2 diabetic patients
pp. 1322-1328(7)
Authors: Matsumoto, K.; Yano, Y.; Gabazza, E. C.; Araki, R.; Bruno, N. E.; Suematsu, M.; Akatsuka, H.; Katsuki, A.; Taguchi, O.; Adachi, Y.; Sumida, Y.

Diabetic neuropathy is closely associated with arterial stiffening and thickness in Type 2 diabetes
pp. 1329-1335(7)
Authors: Yokoyama, H.; Yokota, Y.; Tada, J.; Kanno, S.

Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in Type 2 diabetic patients
pp. 1336-1344(9)
Authors: Chen, H.-S.; Wu, T.-E. J.; Jap, T.-S.; Lu, R.-A.; Wang, M.-L.; Chen, R.-L.; Lin, H.-D.

Increased serum pigment epithelium-derived factor is associated with microvascular complications, vascular stiffness and inflammation in Type 1 diabetes
pp. 1345-1351(7)
Authors: Jenkins, A. J.; Zhang, S. X.; Rowley, K. G.; Karschimkus, C. S.; Nelson, C. L.; Chung, J. S.; O'Neal, D. N.; Januszewski, A. S.; Croft, K. D.; Mori, T. A.; Dragicevic, G.; Harper, C. A.; Best, J. D.; Lyons, T. J.; Ma, J-X.

The impact of site and extent of clinically evident cardiovascular disease and atherosclerotic burden on new cardiovascular events in patients with Type 2 diabetes. The SMART study
pp. 1352-1360(9)
Authors: Gorter, P. M.; Visseren, F. L. J.; Algra, A.; van der Graaf, Y.

Risk factors for coronary disease and stroke in previously hospitalized African-Americans with Type 1 diabetes: a 6-year follow-up
pp. 1361-1368(8)
Authors: Roy, M. S.; Peng, B.; Roy, A.

Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study
pp. 1369-1374(6)
Authors: Ioachimescu, A. G.; Brennan, D. M.; Hoar, B. M.; Kashyap, S. R.; Hoogwerf, B. J.

Usefulness of a new indicator test for the diagnosis of peripheral and autonomic neuropathy in patients with diabetes mellitus
pp. 1375-1380(6)
Authors: Liatis, S.; Marinou, K.; Tentolouris, N.; Pagoni, S.; Katsilambros, N.

Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy—a prospective follow-up study
pp. 1381-1385(5)
Authors: Astrup, A. S.; Tarnow, L.; Christiansen, M.; Hansen, P. R.; Parving, H.-H.; Rossing, P.

Diagnostic potential of serum protein pattern in Type 2 diabetic nephropathy
pp. 1386-1392(7)
Authors: Yang, Y-H.; Zhang, S.; Cui, J-F.; Lu, B.; Dong, X-H.; Song, X-Y.; Liu, Y-K.; Zhu, X-X.; Hu, R-M.

Heterogeneity in disease severity in a family with a novel G68V GCK activating mutation causing persistent hyperinsulinaemic hypoglycaemia of infancy
pp. 1393-1399(7)
Authors: Wabitsch, M.; Lahr, G.; Van de Bunt, M.; Marchant, C.; Lindner, M.; von Puttkamer, J.; Fenneberg, A.; Debatin, K. M.; Klein, R.; Ellard, S.; Clark, A.; Gloyn, A. L.

An angled insertion technique using 6-mm needles markedly reduces the risk of intramuscular injections in children and adolescents
pp. 1400-1405(6)
Authors: Hofman, P. L.; Lawton, S. A.; Peart, J. M.; Holt, J. A.; Jefferies, C. A.; Robinson, E.; Cutfield, W. S.

A randomized cross-over trial to identify the optimal use of insulin glargine in prepubertal children using a three-times daily insulin regimen
pp. 1406-1411(6)
Authors: Fröhlich-Reiterer, E. E.; Ong, K. K.; Regan, F.; Salzano, G.; Acerini, C. L.; Dunger, D. B.

Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK
pp. 1412-1418(7)
Authors: Rubino, A.; McQuay, L. J.; Gough, S. C.; Kvasz, M.; Tennis, P.

Efficacy of continuous subcutaneous insulin infusion in Type 1 diabetes: a 2-year perspective using the established criteria for funding from a National Health Service
pp. 1419-1423(5)
Authors: Giménez, M.; Conget, I.; Jansà, M.; Vidal, M.; Chiganer, G.; Levy, I.

Glycaemic responsiveness to long-term insulin plus sulphonylurea therapy as assessed by sulphonylurea withdrawal
pp. 1424-1429(6)
Authors: Nybäck-Nakell, Å.; Adamson, U.; Lins, P. E.; Landstedt-Hallin, L.

A low-carbohydrate diet is more effective in reducing body weight than healthy eating in both diabetic and non-diabetic subjects
pp. 1430-1435(6)
Authors: Dyson, P. A.; Beatty, S.; Matthews, D. R.

Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes
pp. 1436-1441(6)
Authors: Khunti, K.; Gadsby, R.; Millett, C.; Majeed, A.; Davies, M.

Quality of diabetes care in patients with schizophrenia and bipolar disorder: cross-sectional study
pp. 1442-1448(7)
Authors: Whyte, S.; Penny, C.; Phelan, M.; Hippisley-Cox, J.; Majeed, A.

Serum angiotensin-converting enzyme and frequency of severe hypoglycaemia in Type 1 diabetes: does a relationship exist?
pp. 1449-1454(6)
Authors: Zammitt, N. N.; Geddes, J.; Warren, R. E.; Marioni, R.; Ashby, J. P.; Frier, B. M.

Significant bacteriuria in outpatient diabetic and non-diabetic persons
pp. 1455-1459(5)
Authors: Matteucci, E.; Troilo, A.; Leonetti, P.; Giampietro, O.

The metabolic syndrome as a predictor of incident diabetes mellitus in Mauritius
pp. 1460-1469(10)
Authors: Cameron, A. J.; Zimmet, P. Z.; Soderberg, S.; Alberti, K. G. M. M.; Sicree, R.; Tuomilehto, J.; Chitson, P.; Shaw, J. E.

Lipoatrophy is a thing of the past, or is it?
pp. 1470-1472(3)
Authors: Hussein, S. F.; Siddique, H.; Coates, P.; Green, J.

No evidence of association of the PDCD1 gene with Type 1 diabetes
pp. 1473-1477(5)
Authors: Fawwaz, S.; Nikamo, P.; Törn, C.; Landin-Olsson, M.; Lernmark, Å.; Alarcón-Riquelme, M.; Kockum, I.

Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria
pp. 1478-1481(4)
Authors: Knerr, I.; Hofer, S. E.; Holterhus, P. M.; Näke, A.; Rosenbauer, J.; Weitzel, D.; Wolf, J.; Holl, R. W.

Performance and comparison of the Cockcroft-Gault and simplified Modification of Diet in Renal Disease formulae in estimating glomerular filtration rate in a Chinese Type 2 diabetic population
pp. 1482-1486(5)
Authors: Dong, X.; He, M.; Song, X.; Lu, B.; Yang, Y.; Zhang, S.; Zhao, N.; Zhou, L.; Li, Y.; Zhu, X.; Hu, R.

Low-risk HLA genotype in Type 1 diabetes is associated with less destruction of pancreatic B-cells 12 months after diagnosis
pp. 1487-1490(4)
Authors: Spoletini, M.; Petrone, A.; Zampetti, S.; Capizzi, M.; Zavarella, S.; Osborn, J.; Foffi, C.; Tuccinardi, D.; Pozzilli, P.; Buzzetti, R.

Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men
pp. 1491-1495(5)
Authors: Rochira, V.; Madeo, B.; Zirilli, L.; Caffagni, G.; Maffei, L.; Carani, C.

Climbers with diabetes do well on Mount Kilimanjaro
pp. 1496-1496(1)
Authors: Kalson, N. S.; Davies, A. J.; Stokes, S.; Frost, H.; Whitehead, A. G.; Tyrrell-Marsh, I.; Earl, M. D.

Efficacy of continuous subcutaneous insulin infusion (CSII) in patients with classical contraindications to its use
pp. 1496-1497(2)
Authors: Berkeley, J.; Lunt, H.; Frampton, C.

Use of metformin according to estimated glomerular filtration rate: the threshold and the equation are important
pp. 1498-1499(2)
Authors: Rigalleau, V.; Lasseur, C.; Beauvieux, M.-C.; Chauveau, P.; Raffaitin, C.; Perlemoine, C.; Barthe, N.; Combe, C.; Gin, H.

Estimated glomerular filtration rate (eGFR) and metformin
pp. 1499-1499(1)
Author: Burden, A. C. F.

Reply
pp. 1499-1499(1)
Authors: Warren, R. E.; Strachan, M. W. J.; McKnight, J. A.

List of reviewers 2007
pp. 1500-1503(4)

Indexes
pp. 1504-1528(25)